Related Experiment Videos

Pediatric patient safety events during hospitalization: approaches to accounting for institution-level effects

Anthony D Slonim1, James P Marcin, Wendy Turenne

  • 1Center for Clinical Effectiveness, The George Washington University School of Medicine, 111 Michigan Avenue, NW, Suite 3-100, Washington, DC, USA.

Health Services Research
|November 13, 2007
PubMed

Insights

Patient safety indicators (PSIs) in hospitalized children are infrequent. Analysis of administrative data confirmed significant patient and institutional factors, with similar results across statistical models controlling for institution-level effects.

Area of Science:

  • Pediatric Healthcare Research
  • Health Services Research
  • Patient Safety

Background:

  • Patient safety indicators (PSIs) are crucial for monitoring care quality in pediatric populations.
  • Understanding factors associated with PSIs is essential for targeted interventions.
  • Administrative data offers a broad view of pediatric hospitalizations but requires careful statistical control for institutional variations.

Purpose of the Study:

  • To determine the incidence rates of PSIs in hospitalized children.
  • To identify patient and institutional characteristics associated with PSIs.
  • To evaluate the impact of different statistical methods for controlling institution-level effects on PSI analysis.

Main Methods:

  • Utilized the Pediatric Health Information System dataset for all pediatric discharges in 2003 from 34 children's hospitals.
  • Calculated PSI rates and associated patient/institutional characteristics.
  • Applied three methods to control for institution-level effects: robust standard error estimation, fixed effects, and random effects models.

Main Results:

  • PSIs were infrequent, with rates varying by type (e.g., 0-87 per 10,000).
  • Factors like younger age, Caucasian race, public insurance, extreme illness severity, and larger hospital size were associated with higher PSI rates.
  • All three statistical models controlling for institution-level effects yielded similar clinical and statistical significance.

Conclusions:

  • Various statistical methods can effectively control for institution-level effects in administrative health data analyses.
  • Resource-conservative methods are recommended when clinical implications are minimal.
  • Accurate analysis of PSIs in pediatric populations is achievable with appropriate statistical controls.
Abstract

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...